Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in eosinophilic asthma
ACTRN12606000531516Phase 4Completed
- Sponsor
- Professor D Robin Taylor
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of simvastatin in asthma and eosinophilic asthma (EA), sponsored by Professor D Robin Taylor. Primary endpoint: Optimized dose of inhaled fluticasone. Started Feb 2007; status: completed.
02
Drugs
simvastatin
03
Conditions
asthmaeosinophilic asthma (EA)
Beyond the preview
Go deeper on ACTRN12606000531516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000531516.